BL
JUNO

Bolton LP’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bolton LP’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-28,800
Closed -$1.54M – 202
2015
Q2 		$1.54M Buy
28,800
+6,800
+31% +$361K 0.43% 56
2015
Q1 		$1.33M Buy
+22,000
New +$1.07M 0.35% 60

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $1.33B AUM 1,044.61% 1-Year Est. Return

Bolton LP's JUNO Position: Q3 2015 in Review

Bolton LP sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2015, closing a stake of 25,700 shares — an estimated $1.37M sold.

Bolton LP first reported a position in JUNO in Q1 2015 and held it in 2 quarters. The position peaked at $1.37M in Q2 2015. 132 funds tracked by Wall St. Rank hold JUNO as of Q3 2015.

  • Bolton LP reported no remaining Juno Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Bolton LP sold 25,700 Juno Therapeutics, Inc. shares in Q3 2015, an estimated $1.37M.
  • Bolton LP first reported a position in Juno Therapeutics, Inc. in Q1 2015 and held it in 2 quarters.
  • Bolton LP's Juno Therapeutics, Inc. position peaked at $1.37M in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2015.

Based on Bolton LP's 13F filing for Q3 2015, filed 16 Nov 2015.